Avidity Biosciences Inc. (RNA)

NASDAQ: RNA · Real-Time Price · USD

32.74

0.09 (0.28%)

At close: May 01, 2025, 3:59 PM

34.00

3.85%

After-hours: May 01, 2025, 04:47 PM EDT

Avidity Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-322.3M	-212.22M	-174M	-118.01M	-44.35M	-24.73M	-11.22M
Depreciation & Amortization	-18.67M	2.1M	1.39M	639K	373K	348K	383K
Stock-Based Compensation	51.36M	38.22M	27.14M	17.06M	4.31M	406K	60K
Other Working Capital	-49.74M	59.36M	-8.5M	-705K	-3.42M	18.67M	671K
Other Non-Cash Items	-11.26M	-8.3M	-615K	163K	139K	7.35M	447K
Deferred Income Tax	n/a	n/a	n/a	n/a	84K	n/a	n/a
Change in Working Capital	n/a	61.13M	9.82M	5.34M	2.33M	19.12M	671K
Operating Cash Flow	-300.87M	-119.06M	-136.27M	-94.81M	-37.12M	2.49M	-9.65M
Capital Expenditures	-7.07M	-4.23M	-2.82M	-3.74M	-1.09M	-235K	-49K
Cash Acquisitions	n/a	n/a	187.13M	82.52M	n/a	n/a	n/a
Purchase of Investments	-1.43B	-461M	-355.84M	-85.36M	-6.69M	n/a	n/a
Sales Maturities Of Investments	586.4M	335.16M	168.71M	6.58M	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	-187.13M	-82.52M	-6.69M	n/a	n/a
Investing Cash Flow	-854.2M	-130.07M	-189.96M	-82.52M	-7.79M	-235K	-49K
Debt Repayment	n/a	n/a	n/a	n/a	-4.68M	16.65M	4.98M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	-106K	n/a
Other Financial Acitivies	191.81M	2.13M	1.39M	1.64M	466K	65K	162K
Financial Cash Flow	1.19B	93.86M	346.17M	176.32M	272.04M	89.23M	5.14M
Net Cash Flow	37.29M	-155.27M	19.95M	-1.01M	227.13M	91.49M	-4.56M
Free Cash Flow	-307.94M	-123.29M	-139.09M	-98.55M	-38.21M	2.25M	-9.7M